|
|
 | | | |
- close
- close
- close
- close
Market Intelligence Center
May 17
Comment
Novartis AG (NYSE: NVS) closed Thursday's trading session at $75.01. In the past year, the stock has hit a 52-week low of $51.20 and 52-week high of $75.67. Novartis AG (NVS) stock has been showing support around $74.46 and resistance in the...
FiercePharma
May 16
Comment
Actavis has suddenly become the belle of the ball. The Wall Street Journal reports that Novartis is now entertaining a $16 billion bid for the generics maker after a $13 billion offer from Valeant and a $15 billion bid from Mylan both fell flat.
FiercePharma
May 16
Comment
Novartis prevailed in the latest court battle over jawbone injuries in Zometa patients. The company did properly warn patients about the drug's risks, a New Jersey jury determined after a 13-day trial.
Reuters
May 16
Comment
Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday.
FierceBiotech
May 16
Comment
For Amgen and Novartis, investing in the latest fund from Atlas Venture wasn't enough. The Cambridge, MA-based venture firm has struck separate agreements with the two major drugmakers to join forces on biotech startups.
Wall Street Journal
May 15
Comment
A heated takeover battle has erupted around generic-drug company Actavis. Novartis is considering whether to enter the fray, while Valeant and Mylan are evaluating their options after approaches they made for Actavis were rebuffed.
FiercePharma
May 15
Comment
Novartis is one step closer to knowing how its latest round of Zometa litigation works out. After 11 days of testimony, the jury has started deliberating its verdict on plaintiff Beverly Meng's claims that the Swiss drugmaker downplayed the bone...
The Economic Times
May 14
Comment
Novartis India on Tuesday reported a 25.82 per cent dip in its net profit to Rs 24.41 crore for the quarter ended March 31, 2013.
The Hindu Business Line
May 13
Comment
Novartis India has announced the next edition of the Novartis Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from July 8-10, 2013.
BioCamp is a seminar orga...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
